JFA
UTHR icon

JNBA Financial Advisors’s United Therapeutics UTHR Stock Holding History

JNBA Financial Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Hold
3
– – ﹤0.01% 737
2026
Q1 		$1.78K Hold
3
– – ﹤0.01% 742
2025
Q4 		$1.46K Buy
+3
New +$1.4K ﹤0.01% 706
2016
Q4 		– Sell
-226
Closed -$27K – 1312
2016
Q3 		$27K Buy
+226
New +$27.2K ﹤0.01% 716

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

JNBA Financial Advisors's UTHR Position: Q2 2026 in Review

JNBA Financial Advisors held its United Therapeutics (UTHR) position steady in Q2 2026 at 3 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

JNBA Financial Advisors first reported a position in UTHR in Q3 2016 and has held it in 4 quarters since. The position peaked at $27K in Q3 2016. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • JNBA Financial Advisors held 3 shares of United Therapeutics worth $1.63K as of Q2 2026.
  • JNBA Financial Advisors left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #737 holding.
  • JNBA Financial Advisors first reported a position in United Therapeutics in Q3 2016 and has held it in 4 quarters since.
  • JNBA Financial Advisors's United Therapeutics position peaked at $27K in Q3 2016.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.